AMANDA CAPUTO: Open Payments
NPI 1851955678 · LEWES, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$437 in 21 payments from 11 companies in 2025. Trend: 2023 $1,133 · 2024 $875 · 2025 $437
Food & beverage: $437
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $70 |
| Novo Nordisk Inc | 3 | $60 |
| PFIZER INC. | 3 | $59 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| SCPHARMACEUTICALS INC. | 2 | $37 |
| Tactile Systems Technology Inc | 2 | $35 |
| Actelion Pharmaceuticals US, Inc. | 1 | $27 |
| Amgen Inc. | 1 | $26 |
| Medtronic, Inc. | 1 | $21 |
Products named: Kerendia, LEQVIO, VYNDAQEL, Wegovy, JARDIANCE, FUROSCIX, Flexitouch Plus, OPSYNVI.
Industry payments across DE — which companies pay providers there.
